01—Abstract
Summary
Summary of the 10-K filed March 3, 2014. Cited figures are marked; the original filing is the authoritative source.
CME Group Inc.'s 2013 10-K report details a solid operational year marked by a revenue increase driven primarily by higher contract volumes across its various products, including interest rates, equities, foreign exchange, agriculture, energy, and metals.
The company's strategic initiatives, focused on global expansion, product innovation, and enhancing its over-the-counter (OTC) and electronic trading capabilities, appear to be yielding positive results. Despite facing a competitive and evolving regulatory landscape, particularly with the ongoing implementation of the Dodd-Frank Act, CME Group demonstrated resilience. The company's strong financial position is supported by consistent clearing and transaction fee revenues and prudent expense management, allowing for continued investment in technology and services that maintain its market leadership.
Key financial highlights include a modest increase in total revenues compared to the previous year, driven by a 9%a rise in total contract volume. While the average rate per contract saw a slight decrease due to a shift in product mix towards lower-fee interest rate products, the overall revenue growth indicates a healthy operational performance.
CME Group also continued its commitment to shareholder returns through consistent dividend payments and strategic capital allocation. The company's diversified product offering and robust electronic trading platform remain key competitive strengths, positioning it to navigate market volatility and regulatory changes effectively.
02—Key points
Key Highlights
- Total revenues increased by 1% to $2.94 billion in 2013, primarily driven by a 9% increase in total contract volume.
- Operating income remained strong at $1.64 billion, though slightly lower than $1.69 billion in 2012, reflecting investments in business growth and expenses related to asset sales.
- Net income attributable to CME Group increased by 9% to $976.8 million in 2013, with diluted EPS rising to $2.92 from $2.70 in 2012.
- Electronic trading continued to dominate, accounting for 86% of contract volume, underscoring the company's technological advantage.
- Interest rate products, particularly U.S. Treasury futures and the Eurodollar back 32 futures, showed significant volume growth, indicating increased hedging and speculative activity in response to market volatility.
- The company continued to expand its global reach and product offerings, including the acquisition of KCBT and increased ownership in the S&P/Dow Jones Indices joint venture.
- Dividends paid to shareholders increased, with a regular quarterly dividend of $0.47 and an additional annual variable dividend of $2.60 declared for 2013.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-KFY2013filed March 3, 2014Financial Statements
FY2013 against FY2012
| Line item | FY2013FY2012 | Change |
|---|---|---|
| Revenue | $2.94B$2.91B | +0.7% |
| Operating Expenses | $1.30B$1.22B | +6.3% |
| Operating Income | $1.64B$1.69B | −3.3% |
| Net Income | $976.80M$896.30M | +9.0% |
| EPS (Basic) | $2.94$2.71 | +8.5% |
| EPS (Diluted) | $2.92$2.70 | +8.1% |
| Shares Outstanding (Basic) | 332.68M331.25M | +0.4% |
| Shares Outstanding (Diluted) | 334.40M332.32M | +0.6% |
05—Questions
Frequently Asked Questions
What were the primary drivers of revenue growth for CME Group in 2013?
CME Group's revenue growth in 2013 was primarily driven by an increase in total contract volume across its diverse product lines, particularly in interest rate and metals products. This growth was supported by market volatility, which increased hedging and speculative activity among clients.
How did regulatory changes, such as Dodd-Frank, impact CME Group's operations in 2013?
The company noted that while some provisions of the Dodd-Frank Act create opportunities, such as increased demand for clearing services in the OTC market, the ongoing implementation and potential for further rulemaking could negatively impact the business. CME Group incurred significant costs to comply with these new regulations.
What is CME Group's strategy for future growth?
CME Group's strategy involves continuing to enhance customer relations, globalizing its business by expanding its customer base worldwide and presence in international financial centers, expanding its OTC market capabilities, and establishing itself as a leading provider of information products and index services.
How does CME Group manage its financial risk, particularly related to its clearing operations?
CME Group manages financial risk through robust risk management standards for its clearing houses, including performance bond requirements, daily mark-to-market processes, and mandatory guaranty fund contributions. They also maintain significant lines of credit to ensure liquidity and cover potential defaults.
06—Continue